Establishing how oral health and dementia are linked could point to better prevention and care.
Meet Esra Hassan, PhD student at Brighton and Sussex Medical School’s Centre for Dementia Studies.
Yesterday (27 September 2022), Eisai Co. Ltd. and Biogen announced top-line results for a major trial on the drug lecanemab in slowing down the progress of Alzheimer’s disease. Alzheimer's Society comments on this Alzheimer’s progression drug hope.
Today the Prime Minister Boris Johnson announced that he will be launching a new ‘national dementia mission’ in honour of the late Dame Barbara Windsor.
Meet Sophie Sanford, PhD student at the UK Dementia Research Institute, University of Cambridge.
Learn about the researchers who are part of our Dementia Research Leaders programme, which supports early career researchers from biomedical, clinical and social science backgrounds.
Learn about Alzheimer's Society's new direction of travel for dementia research from 2022 to 2027.
Thank you for being part of the future of dementia research. Your support will help scientists push forwards towards the discoveries that all of us in the dementia community have been waiting for.